ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

GEN Genuit Group Plc

438,00
1,50 (0,34%)
01 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Genuit Group Plc GEN London Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
1,50 0,34% 438,00 17:35:23
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
431,00 431,00 443,50 438,00 436,50
plus d'informations sur les cotations »
Secteur Industriel
INDUSTRIAL ENGINEERING

Actualités Recentes

Date Heure Source Titre
24/4/202411:39UK RNSGenuit Group PLC Notice of AGM
10/4/202417:24UK RNSGenuit Group PLC Director/PDMR Shareholding
10/4/202417:17UK RNSGenuit Group PLC Director/PDMR Shareholding
09/4/202417:28UK RNSGenuit Group PLC Director Declaration
02/4/202416:56UK RNSGenuit Group PLC Director/PDMR Shareholding
20/3/202416:27UK RNSGenuit Group PLC Director/PDMR Shareholding
12/3/202411:40ALNCNewsGenuit revenue drops on lower divisional sales but profit..
12/3/202408:09ALNCNews*Genuit says 2024 trading has started in line w/..
12/3/202408:00UK RNSGenuit Group PLC Final Results
01/3/202409:30UK RNSGenuit Group PLC Director Declaration
19/2/202410:00UK RNSGenuit Group PLC Notice of Results and Investor Presentation
23/1/202416:49UKREGGenuit Group PLC Holding(s) in Company
23/1/202412:24UKREGGenmab A/S Genmab Announces Net Sales Of Darzalex(R)..
23/1/202400:40UKREGGenmab A/S Genmab Announces Decision In Arbitration Appeal..
09/1/202412:45UKREGGenmab A/S Tivdak(R) (tisotumab vedotin-tftv) Supplemental..
03/1/202406:55UKREGGenmab A/S Transactions With Shares And Linked Securities In..
02/1/202415:52UKREGGenmab A/S Genmab To Present At The 42nd Annual J.P. Morgan..
12/12/202313:00UKREGGenmab A/S Genmab To Hold 2023 R&D Update And Ash Data..
09/12/202318:00UKREGGenmab A/S New Pivotal Data For Bispecific Antibody..
05/12/202323:26UKREGGenmab A/S Capital Increase In Genmab As A Result Of..
27/11/202313:00UKREGGenmab A/S Genmab Announces Positive Regulatory Updates For..
22/11/202308:00UKREGGenuit Group PLC Strategy Progress Update Notification
21/11/202322:45UKREGGenmab A/S Transactions With Shares And Linked Securities In..
21/11/202322:42UKREGGenmab A/S Grant Of Restricted Stock Units To Board Members..
15/11/202310:03ALNCNewsGenuit shares rise as annual profit predicted to exceed..
15/11/202308:00UKREGGenuit Group PLC Trading Update
09/11/202315:14UKREGGenmab A/S Major Shareholder Announcement
09/11/202311:08UKREGGenuit Group PLC Director Declaration
09/11/202311:00UKREGGenmab A/S Genmab To Present At Jefferies London Healthcare..
08/11/202317:09UKREGGenmab A/S Major Shareholder Announcement
07/11/202317:01UKREGGenmab A/S Genmab Announces Financial Results For The First..
02/11/202314:05UKREGGenmab A/S Genmab Announces Multiple Abstracts To Be..
02/11/202312:59UKREGGenuit Group PLC Director/PDMR Shareholding
01/11/202317:00UKREGGenuit Group PLC Block listing Interim Review
01/11/202311:58ALNCNewsIN BRIEF: Genuit confirms interim CFO Tim Pullen as..
01/11/202308:00UKREGGenuit Group PLC Directorate Change
25/10/202317:04UKREGGenuit Group PLC Director/PDMR Shareholding
22/10/202316:30UKREGGenmab A/S Tivdak(R) (tisotumab vedotin-tftv) Significantly..
17/10/202317:05UKREGGenuit Group PLC Director/PDMR Shareholding
17/10/202312:22UKREGGenmab A/S Genmab Announces Net Sales Of Darzalex(R)..
11/10/202316:25UKREGGenuit Group PLC Director/PDMR Shareholding
06/10/202316:59UKREGGenuit Group PLC Director/PDMR Shareholding
28/9/202320:38UKREGGenmab A/S Grant Of Restricted Stock Units And Warrants To..
25/9/202313:45UKREGGenmab A/S Genmab Announces European Commission Approval Of..
25/9/202311:55UKREGGenmab A/S Epkinlytm (epcoritamab) Approved By Japan..
12/9/202320:04UKREGGenmab A/S Capital Increase In Genmab As A Result Of..
11/9/202313:56UKREGGenuit Group PLC Director/PDMR Shareholding
04/9/202321:00UKREGGenmab A/S Genmab And Seagen Announce That Tivdak(R)..
01/9/202312:19ALNCNewsIN BRIEF: Genuit hires former Arm, IQE exec Tim Pullen as..
01/9/202311:24DJNGenuit Appoints Tim Pullen as Interim CFO

Dernières Valeurs Consultées

Delayed Upgrade Clock